Medicus Pharma (MDCX) Competitors $7.71 +0.09 (+1.18%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock MDCX vs. SNDL, AUTL, CYRX, BNTC, DBVT, OLMA, FULC, TRDA, SEPN, and ARCTShould you be buying Medicus Pharma stock or one of its competitors? The main competitors of Medicus Pharma include SNDL (SNDL), Autolus Therapeutics (AUTL), Cryoport (CYRX), Benitec Biopharma (BNTC), DBV Technologies (DBVT), Olema Pharmaceuticals (OLMA), Fulcrum Therapeutics (FULC), Entrada Therapeutics (TRDA), Septerna (SEPN), and Arcturus Therapeutics (ARCT). These companies are all part of the "pharmaceutical products" industry. Medicus Pharma vs. SNDL Autolus Therapeutics Cryoport Benitec Biopharma DBV Technologies Olema Pharmaceuticals Fulcrum Therapeutics Entrada Therapeutics Septerna Arcturus Therapeutics SNDL (NASDAQ:SNDL) and Medicus Pharma (NASDAQ:MDCX) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, profitability, earnings, media sentiment, dividends, analyst recommendations, community ranking and valuation. Does the MarketBeat Community prefer SNDL or MDCX? SNDL received 133 more outperform votes than Medicus Pharma when rated by MarketBeat users. However, 100.00% of users gave Medicus Pharma an outperform vote while only 71.94% of users gave SNDL an outperform vote. CompanyUnderperformOutperformSNDLOutperform Votes14171.94% Underperform Votes5528.06% Medicus PharmaOutperform Votes8100.00% Underperform VotesNo Votes Does the media prefer SNDL or MDCX? In the previous week, SNDL had 2 more articles in the media than Medicus Pharma. MarketBeat recorded 4 mentions for SNDL and 2 mentions for Medicus Pharma. SNDL's average media sentiment score of 1.35 beat Medicus Pharma's score of -0.05 indicating that SNDL is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SNDL 2 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Medicus Pharma 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts prefer SNDL or MDCX? SNDL presently has a consensus price target of $3.63, indicating a potential upside of 176.72%. Medicus Pharma has a consensus price target of $23.50, indicating a potential upside of 204.80%. Given Medicus Pharma's stronger consensus rating and higher possible upside, analysts plainly believe Medicus Pharma is more favorable than SNDL.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SNDL 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Medicus Pharma 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 2 Strong Buy rating(s) 3.50 Is SNDL or MDCX more profitable? Medicus Pharma has a net margin of 0.00% compared to SNDL's net margin of -12.11%. Medicus Pharma's return on equity of 0.00% beat SNDL's return on equity.Company Net Margins Return on Equity Return on Assets SNDL-12.11% -8.27% -6.96% Medicus Pharma N/A N/A N/A Which has stronger valuation and earnings, SNDL or MDCX? Medicus Pharma has lower revenue, but higher earnings than SNDL. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSNDL$927.61M0.37-$127.91M-$0.29-4.52Medicus PharmaN/AN/AN/AN/AN/A SummaryMedicus Pharma beats SNDL on 8 of the 12 factors compared between the two stocks. Get Medicus Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for MDCX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MDCX vs. The Competition Export to ExcelMetricMedicus PharmaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$104.05M$6.49B$5.36B$8.39BDividend YieldN/A2.66%5.22%4.10%P/E RatioN/A8.9426.5919.72Price / SalesN/A251.55391.61116.20Price / CashN/A65.8538.2534.62Price / BookN/A6.466.794.51Net IncomeN/A$143.98M$3.23B$248.18M7 Day Performance21.99%3.16%4.03%1.14%1 Month Performance89.90%7.60%12.22%15.07%1 Year PerformanceN/A-2.36%16.76%6.59% Medicus Pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MDCXMedicus Pharma1.6001 of 5 stars$7.71+1.2%$23.50+204.8%N/A$104.05MN/A0.00N/AInsider TradeGap UpHigh Trading VolumeSNDLSNDL3.0889 of 5 stars$1.28-3.0%$3.63+183.2%-44.6%$336.35M$927.61M-4.13580News CoveragePositive NewsAUTLAutolus Therapeutics3.2471 of 5 stars$1.22-3.9%$9.32+663.9%-61.9%$324.69M$9.01M-1.01330CYRXCryoport3.0349 of 5 stars$6.47-7.3%$11.00+70.0%-43.2%$324.39M$214.83M-1.911,020News CoveragePositive NewsBNTCBenitec Biopharma2.4444 of 5 stars$13.58+3.0%$24.71+82.0%+33.0%$318.47M$80,000.00-8.9920News CoveragePositive NewsEarnings ReportAnalyst ForecastAnalyst RevisionGap UpDBVTDBV Technologies3.0148 of 5 stars$11.48+4.5%$15.50+35.0%+52.4%$314.44M$15.73M-2.5580Positive NewsGap UpOLMAOlema Pharmaceuticals2.2991 of 5 stars$4.50-3.8%$24.50+444.4%-46.6%$307.62MN/A-2.0570Gap DownFULCFulcrum Therapeutics0.7741 of 5 stars$5.63-2.8%$6.67+18.4%-15.5%$303.90M$80M-18.16100TRDAEntrada Therapeutics2.9644 of 5 stars$7.97-8.4%$25.67+222.0%-46.2%$302.49M$172.22M5.01110News CoverageAnalyst ForecastAnalyst RevisionSEPNSepterna2.0785 of 5 stars$10.16+51.0%$33.00+224.8%N/A$299.59M$1.08M0.00N/AEarnings ReportAnalyst RevisionHigh Trading VolumeARCTArcturus Therapeutics2.9583 of 5 stars$10.84-8.6%$57.80+433.2%-58.4%$293.99M$138.39M-4.88180 Related Companies and Tools Related Companies SNDL Alternatives Autolus Therapeutics Alternatives Cryoport Alternatives Benitec Biopharma Alternatives DBV Technologies Alternatives Olema Pharmaceuticals Alternatives Fulcrum Therapeutics Alternatives Entrada Therapeutics Alternatives Septerna Alternatives Arcturus Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MDCX) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medicus Pharma Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Medicus Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MDCX Stock Free MDCX Stock Alerts